Skip to Content
Merck
  • Preventive effects of dehydroepiandrosterone acetate on the fatty liver induced by orotic acid in male rats.

Preventive effects of dehydroepiandrosterone acetate on the fatty liver induced by orotic acid in male rats.

Experimental animals (1999-03-06)
H Goto, S Yamashita, T Makita
ABSTRACT

Preventive effects of dehydroepiandrosteone acetate (DHEA-A) and clofibrate (positive control substance) on the fatty liver induced by orotic acid (OA) were examined on the male Sprague-Dawley rats fed a high sucrose based diet containing 1% OA and this diet further mixed with 0.5% DHEA-A or 0.5% clofibrate for 2 weeks. Numerous lipid droplets were observed in the hepatocytes of the rats treated with OA alone, but not in those treated with DHEA-A or clofibrate. In comparison to the group with OA alone, the DHEA-A or clofibrate treated rats showed a larger relative liver weight (to body weight) which was accompanied by increased peroxisomes in the hepatocytes. These results indicate that DHEA-A, as well as clofibrate, may prevent OA-induced fatty liver.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Dehydroisoandrosterone 3-acetate, 97%